市場調査レポート

商品コード

1461557

移植の世界市場規模、シェア、成長分析、用途別、最終用途別-産業予測、2024～2031年

Global Transplantation Market Size, Share, Growth Analysis, By Application(Organ Transplantation, and Tissue Transplantation), By End-Use(Hospitals, Transplant Centers) - Industry Forecast 2024-2031

出版日: 2024年04月05日 | 発行: SkyQuest

| ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 832,842円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 974,268円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,115,694円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の移植市場規模は2022年に150億米ドルと評価され、予測期間（2024～2031年）のCAGRは9.3%で、2023年の164億米ドルから2031年には333億9,000万米ドルに成長する展望です。

移植市場は、臓器不全に苦しむ患者に臓器機能を回復させ、生活の質を高めるための実行可能な選択肢を提供する上で重要な役割を果たしています。その成長の原動力となっているのは、高齢化やライフスタイルの変化といった要因によって、世界的に慢性疾患の有病率が高まっていることです。腎臓病、肝臓病、心不全などの疾患は、移植手術の需要増加に大きく寄与しています。さらに、手術技術、免疫抑制剤、組織工学技術の進歩により、移植の成功率が顕著に向上し、市場の拡大をさらに促しています。しかし、移植手術は複雑なため、専門的なインフラ、熟練した医療専門家、包括的な移植後ケアが必要となり、このセグメントは課題に直面しています。移植前の評価、手術、フォローアップケア、免疫抑制剤など、移植に関連する高額な費用は、医療システムと患者に財政的負担をもたらし、移植サービスへのアクセスに影響を与えます。とはいえ、臓器保存のための機械灌流や新規免疫抑制薬の市場開拓といった技術革新は、移植の成果を高める可能性を秘めており、移植市場には有望な成長機会があります。さらに、臓器提供や移植に関する意識の向上を目指した取り組みや、政府の支援、医療事業体間の連携は、臓器不足に対処し移植プログラムを拡大する上で有望です。急増する需要を満たし、移植サービスへのアクセスを世界的に改善するためには、調査、インフラの強化、一般市民への教育における持続的な取り組みが不可欠です。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主要投資の分析
主要成功要因
競合の程度

市場力学と展望

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

移植の世界市場：用途別

市場概要
臓器移植
組織移植

移植の世界市場：最終用途別

市場概要
病院
移植センター
その他

移植の世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主要市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

Medtronic（米国）
Novartis AG（スイス）
AbbVie Inc.（米国）
Zimmer Biomet Holdings, Inc.（米国）
Stryker Corporation（米国）
CSL Limited（オーストラリア）
Johnson & Johnson（米国）
Roche Holding AG（スイス）
Pfizer Inc.（米国）
Sanofi（フランス）
Merck & Co., Inc.（米国）
Astellas Pharma Inc.（日本）
Bristol-Myers Squibb Company（米国）
Takeda Pharmaceutical Company Limited（日本）
AstraZeneca（英国）
GlaxoSmithKline plc（英国）
Fresenius Medical Care AG & Co. KGaA（ドイツ）
Integra LifeSciences Holdings Corporation（米国）
Organogenesis Holdings Inc.（米国）
Terumo Corporation（日本）

Product Code: SQMIG35D2158

Global Transplantation Market size was valued at USD 15 Billion in 2022 and is poised to grow from USD 16.4 Billion in 2023 to USD 33.39 Billion by 2031, at a CAGR of 9.3% during the forecast period (2024-2031).

The transplantation market plays a crucial role in offering patients suffering from organ failure a viable option to restore organ function and enhance their quality of life. Its growth is fueled by the escalating prevalence of chronic diseases globally, driven by factors like aging populations and lifestyle changes. Conditions such as kidney disease, liver disease, and heart failure contribute significantly to the increasing demand for transplantation procedures. Moreover, advancements in surgical techniques, immunosuppressive medications, and tissue engineering technologies have notably improved transplant success rates, further stimulating market expansion. However, the sector faces challenges due to the intricate nature of transplant procedures, necessitating specialized infrastructure, skilled healthcare professionals, and comprehensive post-transplant care. The high costs associated with transplantation, including pre-transplant evaluations, surgeries, follow-up care, and immunosuppressive medications, create financial strains on healthcare systems and patients, affecting access to transplantation services. Nevertheless, the transplantation market presents promising opportunities for growth, with technological innovations such as machine perfusion for organ preservation and the development of novel immunosuppressive drugs offering potential to enhance transplant outcomes. Additionally, initiatives aimed at increasing awareness about organ donation and transplantation, along with governmental support and collaborations among healthcare entities, hold promise in addressing the organ shortage and expanding transplantation programs. Sustained efforts in research, infrastructure enhancement, and public education are essential to meet the escalating demand and improve access to transplantation services globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transplantation Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transplantation Market Segmental Analysis

The global transplantation market is segmented on the basis of application, end-use, and region. By application, the market is segmented into organ transplantation, and tissue Transplantation. By End-Use, the market is segmented into hospitals, transplant centers, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Transplantation Market

The increasing prevalence of chronic illnesses like end-stage renal disease, liver cirrhosis, heart failure, and respiratory disorders has driven the need for organ transplantation. This is evidenced by the surge in demand for procedures such as kidney and pancreas transplants, spurred by the expanding diabetic population and its associated complications.

Restraints in the Global Transplantation Market

The process of organ transplantation encompasses substantial expenses, spanning from pre-transplant assessments to surgery, post-operative recuperation, and the ongoing necessity of immunosuppressive drugs. These financial demands place strains on patients, healthcare systems, and insurance companies alike. Moreover, the inadequate coverage and reimbursement schemes for transplant-related procedures exacerbate the challenges surrounding the affordability and availability of transplantation services.

Market Trends of the Global Transplantation Market

Precision medicine strategies seek to customize transplant treatments by taking into account unique genetic profiles, immunological compatibility, and specific disease attributes. This approach involves employing biomarkers, genetic assessments, and sophisticated diagnostic tools to individualize immunosuppressive treatments, thereby enhancing patient results.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Transplantation Market by Application

Market Overview
Organ Transplantation
and Tissue Transplantation

Global Transplantation Market by End-Use

Market Overview
Hospitals
Transplant Centers
and Others

Global Transplantation Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CSL Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astellas Pharma Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Medical Care AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Holdings Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Organogenesis Holdings Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments